With increasingly novel drug development programs, meaningful collection of subject samples has never been more relevant. Don’t let potential analyte instability mislead your program as it gets underway, causing costly time delays. Sample integrity knowledge will assist you to ask relevant questions of your potential clinical sites and better understand your bioanalytical needs. In this webinar, we will discuss some of the issues related to subject sample collection to ensure reliable data for your drug program.
19
Dec
